Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ID110521156 in Healthy Adult Subjects

Clinical trial NCT06635226 · RECRUITING

Trial details

NCT number: NCT06635226
Sponsor: IlDong Pharmaceutical Co Ltd
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Adult Subjects

Start date: 2024-11-13
Primary completion: 2025-06-19
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.